MILabs recently introduced its 7th generation of PET, SPECT, CT, and Optical Tomography imagers. Together with its customers and partners, the company has succeeded time after time in opening-up new perspectives, transforming major challenges into major opportunities, and making the impossible possible:
• Photon energy imaging from 1eV to 1 MeV
• SPECT imaging at 120-micron resolution
• PET with positron-range blur elimination
• Best PET /SPECT sensitivity and resolution
• Optical CT with deep tissue quantitation
• Simultaneous PET/PET and PET/SPECT
• Sub-mm Radiotherapy imaging w/o surrogates For further information, click here.
Unfazed by court challenges from competitors
Occasionally, MILabs’ PET/SPECT/CT performance superiority is challenged by its competitors. For example, the outcome of a public tender may be disappointing to the competition.
In such a recent case handled by the Court of the Hague, Bruker-Molecubes challenged the decision of the Radboud UMC to award an EU public tender to MILabs. The clear-cut judgment in the summary proceedings of 21 December 2021 of the court confirmed that MILabs’ configuration scored significantly higher on image quality, flexibility, and upgradeability. In addition, MILabs systems provide better radiation protection to users.
Unique solutions that shape molecular imaging progress
With its new series 7 integrated line of products, MILabs has focused on elevating the user experience by how well each modality works on its own and how much better when all of them work together.
Prof. F. Beekman, founder, and CEO of MILabs who masterminds the development of MILabs products explains in a video presentation that MILabs imaging progress is a result of challenging the limits of imagination. The subject video was recorded during the 2021 Bruce Hasegawa Memorial Lecture at the University of California, San Francisco. Click here to listen and view the presentation.
How prompt gamma imaging enhances preclinical PET
As recently featured in Physics World, TU Delft researchers in collaboration with MILabs forced a breakthrough in preclinical PET imaging by utilizing both prompt gammas and annihilation photons. As illustrated, this approach improves the image quality of 18F PET and furthermore, enables sub-mm imaging of PET isotopes with a long positron range such as 89Zr, 124I, 82Rb. Until now, most of these isotopes were not suited for many preclinical applications.
Moreover, by adding these capabilities to MILabs’ VECTor, concurrent imaging of multiple PET and PET/SPECT isotopes at sub-mm resolution can be done. Hence, for the first time, images for such dual tracer experiments can be obtained with spatial and temporal co-registration. There are already numerous examples where such dual-tracer approaches can provide a better understanding of biological systems. Click here for more information.
MILabs seeks talented individuals to further scale-up its organization.